Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 100
Filtrar
1.
An Bras Dermatol ; 97(2): 231-235, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-34996656

RESUMEN

Patients with lepromatous or borderline leprosy may present two types of vasculonecrotic reactions: Lucio's phenomenon (LP) and necrotic erythema nodosum leprosum (nENL). These are serious conditions, which mostly lead to life-threatening infectious and thrombotic complications. The authors report the case of a patient with leprosy recurrence associated with an atypical type II reaction with LP characteristics on histopathology.


Asunto(s)
Eritema Nudoso , Lepra Dimorfa , Lepra Lepromatosa , Lepra Multibacilar , Lepra , Eritema Nudoso/patología , Humanos , Lepra/complicaciones , Lepra Lepromatosa/complicaciones , Lepra Lepromatosa/patología , Lepra Multibacilar/complicaciones , Necrosis
2.
Rev. chil. infectol ; Rev. chil. infectol;38(5): 707-712, oct. 2021. ilus, tab
Artículo en Español | LILACS | ID: biblio-1388287

RESUMEN

Resumen La lepra o enfermedad de Hansen es una de las clásicas enfermedades olvidadas que aún persiste en Perú. La infección es ocasionada por Mycobacterium leprae. La enfermedad varía en un amplio rango de manifestaciones desde la lepra tuberculoide (paucibacilar) hasta la lepromatosa (multibacilar). Se presenta el caso de un varón de 55 años, agricultor y extractor de madera, procedente de la Amazonia peruana, con lesiones cutáneas antiguas infiltrantes en la cara, cuello, tórax, abdomen y extremidades. La baciloscopia y estudio histológico de una biopsia de piel confirmaron la presencia de bacilos ácido-alcohol resistentes. Se concluyó, en forma tardía, que fue un caso de lepra lepromatosa nodular. Recibió terapia con rifampicina, dapsona y clofamizina por dos años con una lenta mejoría; no obstante, cursó con un eritema nodoso leproso (reacción tipo 2) con buena respuesta a corticoesteroides y talidomida.


Abstract Leprosy or Hansen's disease is one of the classic neglected diseases that still persists in Peru. The infection is caused by Mycobacterium leprae. The disease varies in a wide range of manifestations from tuberculoid (paucibacillary) to lepromatous (multibacillary) leprosy. We present the case of a 55-year-old man, farmer and wood extractor, from the Peruvian Amazon with old infiltrating cutaneous lesions on the face, neck, thorax, abdomen and extremities. The smear and biopsy examinations confirm the presence of acid-alcohol-resistant bacilli compatible with leprosy. It is concluded, with a long delay, it was a case of nodular lepromatous leprosy. He received therapy with rifampicin, dapsone and clofamizine for two years with slow progressive improvement; however, he presented an erythema nodosum leprosum (type 2 reaction) with response to corticosteroids and thalidomide.


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Lepra Lepromatosa/diagnóstico , Eritema Nudoso/diagnóstico , Eritema Nudoso/patología , Perú , Lepra Lepromatosa/tratamiento farmacológico , Eritema Nudoso/tratamiento farmacológico , Diagnóstico Tardío , Lepra
3.
Rev Chilena Infectol ; 38(5): 707-712, 2021 10.
Artículo en Español | MEDLINE | ID: mdl-35506839

RESUMEN

Leprosy or Hansen's disease is one of the classic neglected diseases that still persists in Peru. The infection is caused by Mycobacterium leprae. The disease varies in a wide range of manifestations from tuberculoid (paucibacillary) to lepromatous (multibacillary) leprosy. We present the case of a 55-year-old man, farmer and wood extractor, from the Peruvian Amazon with old infiltrating cutaneous lesions on the face, neck, thorax, abdomen and extremities. The smear and biopsy examinations confirm the presence of acid-alcohol-resistant bacilli compatible with leprosy. It is concluded, with a long delay, it was a case of nodular lepromatous leprosy. He received therapy with rifampicin, dapsone and clofamizine for two years with slow progressive improvement; however, he presented an erythema nodosum leprosum (type 2 reaction) with response to corticosteroids and thalidomide.


Asunto(s)
Eritema Nudoso , Lepra Lepromatosa , Lepra , Diagnóstico Tardío , Eritema Nudoso/diagnóstico , Eritema Nudoso/tratamiento farmacológico , Eritema Nudoso/patología , Humanos , Lepra Lepromatosa/diagnóstico , Lepra Lepromatosa/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Perú
4.
Semin Respir Crit Care Med ; 41(5): 733-740, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32777854

RESUMEN

Sarcoidosis is a systemic granulomatous disease of unknown etiology. The outcome is quite variable and is mainly related to persistent inflammatory processes and the development of fibrosis. Many prognostic factors have been described, but the disease evolution is not yet entirely known. The nonthreatening course is characterized by spontaneous involution or stability after treatment withdrawal. Löfgren's syndrome is a subset within the spectrum of sarcoidosis phenotypes, composed of acute onset of fever, bilateral hilar lymphadenopathy, erythema nodosum and/or bilateral ankle periarticular inflammation/arthritis, specifically characterized by a self-limiting disease course. In contrast, advanced fibrotic sarcoidosis with pulmonary hypertension phenotype is correlated with a poor prognosis. Further studies are necessary to detail phenotypes to better understand the mechanisms of the disease and plan future clinical therapeutic studies.


Asunto(s)
Artritis/diagnóstico , Eritema Nudoso/diagnóstico , Sarcoidosis/diagnóstico , Articulación del Tobillo , Artritis/patología , Eritema Nudoso/patología , Humanos , Hipertensión Pulmonar/etiología , Sarcoidosis/patología , Síndrome
5.
Int J Dermatol ; 59(7): 856-861, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32358972

RESUMEN

BACKGROUND: Leprosy can cause acute reactions, which may be type 1 (reverse reaction) or type 2 (erythema nodosum leprosum - ENL). ENL has been classified as mild, moderate, or severe. In order to standardize the classification, the Erythema Nodosum Leprosum International Study (ENLIST) Group has developed an objective scale, the ENLIST ENL Severity Scale (EESS), which was the first validated severity scale of ENL in the world. The goal of the study was to describe the sociodemographic and clinical characteristics of patients with ENL attending a tertiary hospital in Piauí, Brazil, classifying them according to the EESS. METHODS: A descriptive cross-sectional observational study was conducted on 26 patients recruited sequentially from May 2017 to February 2018. Their data were statistically analyzed and compared against each other through a structured questionnaire. RESULTS: According to the score obtained in the scale, the patients were divided into two groups: mild ENL and moderate/severe ENL. The extent and number of nodules were related to the severity of the cases, and these data were statistically significant. The majority of the patients were male, between the ages of 31 and 49 years old, with low educational level, and residents in the urban area. CONCLUSIONS: This was the first study to use EESS in Brazil. This scale is easy to apply and allows for the enhancement of treatment protocols. The study also showed a correlation between the number and extension of nodules and the severity of the condition.


Asunto(s)
Eritema Nudoso/epidemiología , Lepra Lepromatosa/epidemiología , Índice de Severidad de la Enfermedad , Adolescente , Adulto , Brasil/epidemiología , Estudios Transversales , Escolaridad , Eritema Nudoso/complicaciones , Eritema Nudoso/patología , Femenino , Fiebre/microbiología , Humanos , Lepra Lepromatosa/complicaciones , Lepra Lepromatosa/patología , Masculino , Persona de Mediana Edad , Dolor/microbiología , Prevalencia , Factores Sexuales , Encuestas y Cuestionarios , Población Urbana , Adulto Joven
7.
Adv Rheumatol ; 59(1): 35, 2019 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-31370889

RESUMEN

The panniculitides remain as one of the most challenging areas for clinicians, as they comprise a heterogeneous group of inflammatory diseases involving the subcutaneous fat with potentially-shared clinical and histopathological features. Clinically, most panniculitides present as red edematous nodules or plaques. Therefore, in addition to a detailed clinical history, a large scalpel biopsy of a recent-stage lesion with adequate representation of the subcutaneous tissue is essential to specific diagnosis and appropriate clinical management. Herein we review the panniculitides of particular interest to the rheumatologist.


Asunto(s)
Paniculitis/patología , Reumatólogos , Síndrome de Behçet/patología , Biopsia/métodos , Eritema Indurado/patología , Eritema Nudoso/patología , Etanercept/efectos adversos , Humanos , Inmunosupresores/efectos adversos , Infecciones/patología , Paniculitis/clasificación , Paniculitis de Lupus Eritematoso/patología , Poliarteritis Nudosa/patología , Grasa Subcutánea/patología , Tejido Subcutáneo/patología , Vasculitis/patología
9.
Pharmacogenomics ; 20(7): 503-516, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-31124417

RESUMEN

Aim: To evaluate the effects of gene polymorphisms in the treatment of erythema nodosum leprosum with prednisone/thalidomide. Patients & methods: A total of 152 patients from different regions of Brazil were included. Generalized estimating equation was used to evaluate the influence of polymorphisms and haplotypes on the drug dose variation throughout the treatment. Results: An association between the genotype tuberculoid of polymorphism ABCB1 3435C>T (rs1045642; p = 0.02) and prednisone dose was found in the recessive model. An association between the haplotypes 1031T/-863C/-857C/-308A/-238G (p = 0.006) and 1031T/-863C/-857T/-308A/-238G (p = 0.040) of the TNF gene and the CYP2C19*2 polymorphism were also identified, in relation to thalidomide dosage variation over the course of treatment. Conclusion: This work presents the first pharmacogenetic report of association between gene polymorphisms and erythema nodosum leprosum treatment with prednisone/thalidomide.


Asunto(s)
Citocromo P-450 CYP2C19/genética , Eritema Nudoso/tratamiento farmacológico , Factor de Necrosis Tumoral alfa/genética , Subfamilia B de Transportador de Casetes de Unión a ATP/genética , Adulto , Brasil/epidemiología , Relación Dosis-Respuesta a Droga , Eritema Nudoso/genética , Eritema Nudoso/patología , Femenino , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Genotipo , Haplotipos/genética , Humanos , Masculino , Polimorfismo Genético , Prednisona/administración & dosificación , Prednisona/efectos adversos , Receptores de Glucocorticoides/genética , Talidomida/administración & dosificación , Talidomida/efectos adversos
10.
Am J Trop Med Hyg ; 100(2): 377-385, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30652669

RESUMEN

Type 2 reaction (T2R) or erythema nodosum leprosum (ENL), a sudden episode of acute inflammation predominantly affecting lepromatous leprosy patients (LL), characterized by a reduced cellular immune response. This possibly indicates a close relationship between the onset of T2R and the altered frequency, and functional activity of T lymphocytes, particularly of memory subsets. This study performed ex vivo and in vitro characterizations of T cell blood subpopulations from LL patients with or without T2R. In addition, the evaluation of activity of these subpopulations was performed by analyzing the frequency of these cells producing IFN-γ, TNF, and IL-10 by flow cytometry. Furthermore, the expression of transcription factors, for the differentiation of T cells, were analyzed by quantitative real-time polymerase chain reaction. Our results showed an increased frequency of CD8+/TNF+ effector memory T cells (TEM) among T2Rs. Moreover, there was evidence of a reduced frequency of CD4 and CD8+ IFN-γ-producing cells in T2R, and a reduced expression of STAT4 and TBX21. Finally, a significant and positive correlation between bacteriological index (BI) of T2R patients and CD4+/TNF+ and CD4+/IFN-γ+ T cells was observed. Thus, negative correlation between BI and the frequency of CD4+/IL-10+ T cells was noted. These results suggest that CD8+/TNF+ TEM are primarily responsible for the transient alteration in the immune response to Mycobacterium leprae in ENL patients. Thus, our study improves our understanding of pathogenic mechanisms and might suggest new therapeutic approaches for leprosy.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Eritema Nudoso/inmunología , Lepra Lepromatosa/inmunología , Mycobacterium leprae/patogenicidad , Factor de Necrosis Tumoral alfa/inmunología , Adolescente , Adulto , Anciano , Linfocitos T CD4-Positivos/microbiología , Linfocitos T CD8-positivos/microbiología , Estudios de Casos y Controles , Eritema Nudoso/genética , Eritema Nudoso/patología , Femenino , Regulación de la Expresión Génica , Interacciones Huésped-Patógeno/genética , Interacciones Huésped-Patógeno/inmunología , Humanos , Memoria Inmunológica , Inmunofenotipificación , Interferón gamma/genética , Interferón gamma/inmunología , Interleucina-10/genética , Interleucina-10/inmunología , Lepra Lepromatosa/genética , Lepra Lepromatosa/patología , Masculino , Persona de Mediana Edad , Mycobacterium leprae/crecimiento & desarrollo , Mycobacterium leprae/inmunología , Cultivo Primario de Células , Factor de Transcripción STAT4/genética , Factor de Transcripción STAT4/inmunología , Transducción de Señal , Proteínas de Dominio T Box/genética , Proteínas de Dominio T Box/inmunología , Factor de Necrosis Tumoral alfa/genética
11.
J Infect Dis ; 216(12): 1635-1643, 2017 12 19.
Artículo en Inglés | MEDLINE | ID: mdl-29272525

RESUMEN

Background: Leprosy, the leading infectious cause of disability worldwide, remains a major public health challenge in the most severely affected countries despite the sharp decline in new cases in recent years. The search for biomarkers is essential to achieve a better understanding of the molecular and cellular mechanisms underlying the disease. Methods: Pentraxin-3 (PTX3) analyses of sera from 87 leprosy patients with or without reactions were conducted via enzyme-linked immunosorbent assay. In situ identification of PTX3 in skin lesion was confirmed by quantitative reverse-transcription polymerase chain reaction, immunohistochemistry, and immunofluorescence assays. Results: We found that PTX3 serum levels were higher in multibacillary patients when evaluated before the onset of acute erythema nodosum leprosum (ENL) and persistently elevated during reaction. Thalidomide treatment reduced PTX3 in the serum 7 days after starting treatment. In situ analyses have also demonstrated enhancement of PTX3 in ENL lesions and showed that treatment with thalidomide reduced its expression and the prominent neutrophilic infiltrate, a hallmark of the disease. Conclusions: In summary, our study provides in vivo evidence that PTX3 is enhanced during ENL but not in reversal reaction and provides a new molecular target in ENL pathogenesis.


Asunto(s)
Biomarcadores/análisis , Proteína C-Reactiva/análisis , Eritema Nudoso/diagnóstico , Eritema Nudoso/patología , Lepra Lepromatosa/diagnóstico , Lepra Lepromatosa/patología , Componente Amiloide P Sérico/análisis , Adolescente , Adulto , Anciano , Proteína C-Reactiva/genética , Estudios de Casos y Controles , Niño , Ensayo de Inmunoadsorción Enzimática , Femenino , Técnica del Anticuerpo Fluorescente , Humanos , Inmunohistoquímica , Leprostáticos/administración & dosificación , Masculino , Persona de Mediana Edad , Reacción en Cadena en Tiempo Real de la Polimerasa , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Componente Amiloide P Sérico/genética , Piel/patología , Talidomida/administración & dosificación , Adulto Joven
12.
An Bras Dermatol ; 90(5): 756-7, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26560226

RESUMEN

Leprosy is a neglected disease. We point up the need of recognizing the unusual clinical presentations of the disease in order to make early diagnosis and proper treatment possible, and break the transmission chain. The authors report a rare type of multibacillary leprosy: histoid leprosy and present images of numerous well-circumscribed indurated papules and nodules distributed throughout the entire body.


Asunto(s)
Lepra Lepromatosa/patología , Biopsia , Eritema Nudoso/patología , Humanos , Masculino , Enfermedades Raras/patología , Adulto Joven
13.
An Bras Dermatol ; 90(4): 561-3, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26375227

RESUMEN

Erythema elevatum diutinum is a rare chronic leukocytoclastic vasculitis of unknown etiology. It is believed to be due to deposition of immune complexes in the vessels. Clinically it is manifested as erythematous violaceous papules and nodules, isolated or confluent with hardened consistency, symmetrical, usually located on the extensor surface of the extremities, particularly over the joints. Diagnosis is based on clinical and histological findings. We report the case of a woman, 71 years old, with erythematous violaceous nodules on the hands, elbows, back and legs, beginning two years ago, with pain and itching. Histopathological analysis revealed leukocytoclastic vasculitis, confirming the clinical suspicion. Laboratory tests revealed hypothyroidism. We report the case because of its rarity, with subsequent review of the literature.


Asunto(s)
Hipotiroidismo/complicaciones , Vasculitis Leucocitoclástica Cutánea/complicaciones , Anciano , Enfermedad Crónica , Eritema Nudoso/complicaciones , Eritema Nudoso/patología , Femenino , Humanos , Hipotiroidismo/patología , Vasculitis Leucocitoclástica Cutánea/patología
14.
An. bras. dermatol ; An. bras. dermatol;90(4): 561-563, July-Aug. 2015. ilus
Artículo en Inglés | LILACS | ID: lil-759203

RESUMEN

AbstractErythema elevatum diutinum is a rare chronic leukocytoclastic vasculitis of unknown etiology. It is believed to be due to deposition of immune complexes in the vessels. Clinically it is manifested as erythematous violaceous papules and nodules, isolated or confluent with hardened consistency, symmetrical, usually located on the extensor surface of the extremities, particularly over the joints. Diagnosis is based on clinical and histological findings. We report the case of a woman, 71 years old, with erythematous violaceous nodules on the hands, elbows, back and legs, beginning two years ago, with pain and itching. Histopathological analysis revealed leukocytoclastic vasculitis, confirming the clinical suspicion. Laboratory tests revealed hypothyroidism. We report the case because of its rarity, with subsequent review of the literature.


Asunto(s)
Anciano , Femenino , Humanos , Hipotiroidismo/complicaciones , Vasculitis Leucocitoclástica Cutánea/complicaciones , Enfermedad Crónica , Eritema Nudoso/complicaciones , Eritema Nudoso/patología , Hipotiroidismo/patología , Vasculitis Leucocitoclástica Cutánea/patología
15.
An Bras Dermatol ; 90(2): 237-9, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25830995

RESUMEN

We report the case of a 54-year-old woman with concurrent Sweet's syndrome, pathergy phenomenon and eythema nodosum-like lesions associated with suppurative tonsillitis. Tender, violaceous and highly edematous papules and plaques were detected on the forearms and legs, some of which were pseudovesicular. Similar edematous papules were detected on the dorsum of the hands at the sites of intravenous injection. Biopsies of a plaque on the forearm and a papule at the site of intravenous injection confirmed the presence of Sweet's syndrome. Multiple, tender, violet-red, subcutaneous erythematous nodules were revealed on the legs. A biopsy taken from a nodule on the leg revealed septal panniculitis. To our knowledge, no patient with concurrent Sweet's syndrome, pathergy phenomenon, and erythema nodosum-lesions had been reported yet in previous literature.


Asunto(s)
Eritema Nudoso/patología , Síndrome de Sweet/patología , Biopsia , Eritema Nudoso/complicaciones , Femenino , Humanos , Persona de Mediana Edad , Paniculitis/complicaciones , Paniculitis/patología , Piel/patología , Síndrome de Sweet/complicaciones
16.
An. bras. dermatol ; An. bras. dermatol;90(2): 237-239, Mar-Apr/2015. graf
Artículo en Inglés | LILACS | ID: lil-741074

RESUMEN

We report the case of a 54-year-old woman with concurrent Sweet's syndrome, pathergy phenomenon and eythema nodosum-like lesions associated with suppurative tonsillitis. Tender, violaceous and highly edematous papules and plaques were detected on the forearms and legs, some of which were pseudovesicular. Similar edematous papules were detected on the dorsum of the hands at the sites of intravenous injection. Biopsies of a plaque on the forearm and a papule at the site of intravenous injection confirmed the presence of Sweet's syndrome. Multiple, tender, violet-red, subcutaneous erythematous nodules were revealed on the legs. A biopsy taken from a nodule on the leg revealed septal panniculitis. To our knowledge, no patient with concurrent Sweet's syndrome, pathergy phenomenon, and erythema nodosum-lesions had been reported yet in previous literature.


Asunto(s)
Femenino , Humanos , Persona de Mediana Edad , Eritema Nudoso/patología , Síndrome de Sweet/patología , Biopsia , Eritema Nudoso/complicaciones , Paniculitis/complicaciones , Paniculitis/patología , Piel/patología , Síndrome de Sweet/complicaciones
17.
In. Virmond, Marcos da Cunha Lopes; Grzybowski, Andrzej. Clinics in Dermatology: Leprosy: 1. New York, Elsevier, 2015. p.38-45, ilus.
No convencional en Inglés | Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1048274

RESUMEN

The histopathology of lepromatous skin varies according to the cell-mediated immunity of the host against Mycobacterium leprae. In tuberculoid and borderline tuberculoid leprosy, epithelioid noncaseating granulomas predominate, and acid-fast bacilli (AFB) are absent or only rarely present. In borderline lepromatous and lepromatous leprosy, the infiltrate is composed of macrophages with a vacuolar cytoplasm, lymphocytes, and plasma cells. AFB are numerous. Edema inside and outside the epithelioid granulomas, together with the appearance of large giant cells, are the main features of type 1 reactions. A conspicuous neutrophilic infiltrate in the subcutis with or without vasculitis is found in erythema nodosum leprosum. The main histopathologic features of leprosy and its particular forms are discussed in this review.


Asunto(s)
Humanos , Masculino , Femenino , Piel/patología , Eritema Nudoso/patología , Lepra/fisiopatología , Lepra/patología , Biopsia con Aguja , Inmunohistoquímica , Diagnóstico Diferencial
18.
Biomedica ; 32(1): 13-22, 2012.
Artículo en Español | MEDLINE | ID: mdl-23235783

RESUMEN

INTRODUCTION: Damage of testicles is frequent in lepromatous leprosy and worsened by the presence of erythema nodosum leprosum. Objective. A patient is presented who developed lepromatous leprosy and erythema nodosum leprosum with major testicular compromise. MATERIAL AND METHODS: The 28-year-old male patient had lepromatous leprosy since age 22. During a polychemotherapy treatment for the lepromatous leprosy, he presented chronic erythema nodosum leprosum that affected both testicles; he did not respond to the conventional treatment. A left orchidectomy was performed to treat the persistent pain. RESULTS: The extracted testis evidenced the following: tubular atrophy, extensive fibrosis, cumulus of foamy macrophages without rods, focal Leydig cell hyperplasia, linfocitary and granulomatous arteritis and endarteritis of small and medium size vessels. These changes were also observed in the epididymis. Two years after the polychemoterapy and the orchidectomy, the patient exhibited azoospermy, normal total testosterone, slightly diminished free testosterone and elevated levels of luteinizing hormone and follicle-stimulating hormone. No loss of libido or sexual activity was reported. General concepts of erythema nodosum leprosum were reviewed, as well as the pathologic changes produced by leprosy in the testis. CONCLUSION: Lepromatous leprosy may lead to hypogonadism. This condition is recommended for inclusion in leprosy diagnostic programs in order to detect and treat the consequences of the possible hypogonadism.


Asunto(s)
Eritema Nudoso/etiología , Hipogonadismo/etiología , Lepra Lepromatosa/complicaciones , Enfermedades Testiculares/etiología , Adulto , Atrofia , Azoospermia/etiología , Clofazimina/uso terapéutico , Dapsona/uso terapéutico , Epidídimo/patología , Eritema Nudoso/patología , Eritema Nudoso/cirugía , Fibrosis , Células Espumosas/patología , Hormona Folículo Estimulante/sangre , Humanos , Hiperplasia , Hipogonadismo/sangre , Leprostáticos/uso terapéutico , Lepra Lepromatosa/clasificación , Lepra Lepromatosa/tratamiento farmacológico , Lepra Lepromatosa/inmunología , Lepra Lepromatosa/patología , Células Intersticiales del Testículo/patología , Hormona Luteinizante/sangre , Masculino , Orquiectomía , Rifampin/uso terapéutico , Enfermedades Testiculares/patología , Enfermedades Testiculares/cirugía , Testosterona/sangre , Talidomida/uso terapéutico
19.
Biomédica (Bogotá) ; Biomédica (Bogotá);32(1): 13-22, ene.-mar. 2012. ilus, tab
Artículo en Español | LILACS | ID: lil-639807

RESUMEN

Introducción. La afección testicular es frecuente en la lepra lepromatosa, daño que se incrementa cuando cursa con eritema nudoso leproso. Objetivo. Presentar un paciente con lepra lepromatosa y eritema nudoso leproso con grave compromiso testicular. Materiales y métodos. Se estudió un hombre de 28 años con lepra lepromatosa desde los 22, que durante la poliquimioterapia para la lepra presentó eritema nudoso leproso crónico que afectó ambos testículos y no respondió al manejo convencional. El dolor persistente obligó a practicar orquidectomía izquierda. Resultados. Este testículo presentaba atrofia tubular y fibrosis notorias, conglomerados de macrófagos espumosos, sin bacilos, hiperplasia focal de células de Leydig, endarteritis y arteritis linfocitaria y granulomatosa de vasos pequeños y medianos; estos cambios también estaban presentes en el epidídimo. Un estudio llevado a cabo dos años después de terminar su tratamiento y de la orquidectomía izquierda, demostró azoospermia, testosterona total normal, testosterona libre discretamente disminuida y hormonas lutropina (luteinizante) y folitropina (estimulante del folículo) elevadas. No había disminución de la libido ni de su actividad sexual. Se revisaron los conceptos generales sobre el eritema nudoso leproso y las alteraciones que la lepra produce en el testículo. Conclusión. La lepra lepromatosa puede conducir a hipogonadismo. Los programas de lepra deben contemplar esta complicación para corregir y evitar sus secuelas.


Introduction. Damage of testicles is frequent in lepromatous leprosy and worsened by the presence of erythema nodosum leprosum. Objective. A patient is presented who developed lepromatous leprosy and erythema nodosum leprosum with major testicular compromise. Material and methods. The 28-year-old male patient had lepromatous leprosy since age 22. During a polychemotherapy treatment for the lepromatous leprosy, he presented chronic erythema nodosum leprosum that affected both testicles; he did not respond to the conventional treatment. A left orchidectomy was performed to treat the persistent pain. Results. The extracted testis evidenced the following: tubular atrophy, extensive fibrosis, cumulus of foamy macrophages without rods, focal Leydig cell hyperplasia, linfocitary and granulomatous arteritis and endarteritis of small and medium size vessels. These changes were also observed in the epididymis. Two years after the polychemoterapy and the orchidectomy, the patient exhibited azoospermy, normal total testosterone, slightly diminished free testosterone and elevated levels of luteinizing hormone and follicle-stimulating hormone. No loss of libido or sexual activity was reported. General concepts of erythema nodosum leprosum were reviewed, as well as the pathologic changes produced by leprosy in the testis. Conclusion. Lepromatous leprosy may lead to hypogonadism. This condition is recommended for inclusion in leprosy diagnostic programs in order to detect and treat the consequences of the possible hypogonadism.


Asunto(s)
Adulto , Humanos , Masculino , Eritema Nudoso/etiología , Hipogonadismo/etiología , Lepra Lepromatosa/complicaciones , Enfermedades Testiculares/etiología , Atrofia , Azoospermia/etiología , Clofazimina/uso terapéutico , Dapsona/uso terapéutico , Epidídimo/patología , Eritema Nudoso/patología , Eritema Nudoso/cirugía , Fibrosis , Células Espumosas/patología , Hormona Folículo Estimulante/sangre , Hiperplasia , Hipogonadismo/sangre , Leprostáticos/uso terapéutico , Lepra Lepromatosa/clasificación , Lepra Lepromatosa/tratamiento farmacológico , Lepra Lepromatosa/inmunología , Lepra Lepromatosa/patología , Células Intersticiales del Testículo/patología , Hormona Luteinizante/sangre , Orquiectomía , Rifampin/uso terapéutico , Enfermedades Testiculares/patología , Enfermedades Testiculares/cirugía , Testosterona/sangre , Talidomida/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA